Creative Medical Technology
CELZ
15 hedge funds and large institutions have $176K invested in Creative Medical Technology in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 6 closing their positions.
12% more capital invested
Capital invested by funds: $157K → $176K (+$18.7K)
0.04% less ownership
Funds ownership: 0.29% → 0.25% (-0.04%)
17% less funds holding
Funds holding: 18 → 15 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$51K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12.1K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$5.86K |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$5.68K |
| 5 |
VF
Virtu Financial
New York
|
+$1.87K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWA
Aaron Wealth Advisors
Chicago,
Illinois
|
-$38.1K |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$15.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$11.7K |
| 4 |
SG
StoneX Group
New York
|
-$5.72K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$4K |
CELZ Hedge Fund Activity: Q1 2023 in Review
15 of the 6,282 institutional investors tracked by Wall St. Rank reported a position in Creative Medical Technology (CELZ) for Q1 2023, worth a combined $176K — up 12% from $157K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CELZ and 3 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 3 added.
The largest buyer was Geode Capital Management, adding an estimated $51K. The largest seller was Aaron Wealth Advisors, exiting entirely with an estimated $38.1K sold.
- 15 institutional investors held Creative Medical Technology (CELZ) as of Q1 2023, down from 18 in Q4 2022.
- Funds reported $176K of Creative Medical Technology stock for Q1 2023, up 12% quarter-over-quarter.
- 3 funds opened new Creative Medical Technology positions in Q1 2023 and 6 closed out, a net change of -3 holders.
- The largest Creative Medical Technology buyer in Q1 2023 was Geode Capital Management, an estimated $51K added.
- The largest Creative Medical Technology seller in Q1 2023 was Aaron Wealth Advisors, an estimated $38.1K sold.
Based on aggregated 13F filings for Q1 2023.